RedHill Biopharma | RDHL - Cost Of Sales

Stock Price
1.07
Daily Change
0.04 3.88%
Monthly
-12.30%
Yearly
-80.55%
Q1 Forecast
1.18

RedHill Biopharma reported $702K in Cost of Sales for its fiscal quarter ending in June of 2024.





Cost Of Sales Change Date
Clal Biotechnology ILS 16.49M 2.64M Jun/2022
Compugen USD 1.65M 10K Sep/2025
Cronos Group USD 18.36M 1.28M Sep/2025
RedHill Biopharma USD 702K 0 Jun/2024